IL6 is a pleiotropic cytokine and its circulating level has been identified as a prognostic marker for different CVDs such as AF and CAD.4,5 In the last several years, different biologically-derived drug compounds have been developed to inhibit IL6 signaling. This evidence concerns the gene IL6 and atrial fibrillation.